Cargando…
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews
People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111623/ https://www.ncbi.nlm.nih.gov/pubmed/35184346 http://dx.doi.org/10.1111/dar.13448 |
_version_ | 1784709292036718592 |
---|---|
author | Price, Olivia Dietze, Paul M. Maher, Lisa Crawford, Sione Peacock, Amy |
author_facet | Price, Olivia Dietze, Paul M. Maher, Lisa Crawford, Sione Peacock, Amy |
author_sort | Price, Olivia |
collection | PubMed |
description | People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by presenting vaccine intention data from Illicit Drug Reporting System interviews conducted in June–July 2021, in the early stages of vaccine rollout, with people in Australia who inject drugs (N = 888). Half the sample (48%, n = 419) reported that they were hesitant to receive the COVID‐19 vaccine, with key barriers relating to vaccine safety and side effect concerns. This level of hesitancy is substantially higher than that of the general population at a similar time. While we note that the subsequent Delta variant‐driven third wave of cases in Australia and efforts to increase population vaccination coverage may have altered intent in this group, this level of hesitancy warrants a targeted strategy to mitigate vaccine‐related concerns and maximise uptake. Ideally, this should comprise an inclusive health response that is peer‐led, with peer‐based organisations ideally positioned to direct immunisation service delivery and provide vaccine‐related messaging. |
format | Online Article Text |
id | pubmed-9111623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-91116232022-05-17 COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews Price, Olivia Dietze, Paul M. Maher, Lisa Crawford, Sione Peacock, Amy Drug Alcohol Rev Commentaries People who inject drugs may be at higher risk of COVID‐19 transmission and more severe negative health outcomes following COVID‐19 infection. Early research on hypothetical COVID‐19 vaccines suggests this population may be less likely to accept vaccination. This commentary extends this research by presenting vaccine intention data from Illicit Drug Reporting System interviews conducted in June–July 2021, in the early stages of vaccine rollout, with people in Australia who inject drugs (N = 888). Half the sample (48%, n = 419) reported that they were hesitant to receive the COVID‐19 vaccine, with key barriers relating to vaccine safety and side effect concerns. This level of hesitancy is substantially higher than that of the general population at a similar time. While we note that the subsequent Delta variant‐driven third wave of cases in Australia and efforts to increase population vaccination coverage may have altered intent in this group, this level of hesitancy warrants a targeted strategy to mitigate vaccine‐related concerns and maximise uptake. Ideally, this should comprise an inclusive health response that is peer‐led, with peer‐based organisations ideally positioned to direct immunisation service delivery and provide vaccine‐related messaging. John Wiley & Sons Australia, Ltd 2022-02-20 2022-07 /pmc/articles/PMC9111623/ /pubmed/35184346 http://dx.doi.org/10.1111/dar.13448 Text en © 2022 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Commentaries Price, Olivia Dietze, Paul M. Maher, Lisa Crawford, Sione Peacock, Amy COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title |
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title_full |
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title_fullStr |
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title_full_unstemmed |
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title_short |
COVID‐19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews |
title_sort | covid‐19 vaccine acceptability among people in australia who inject drugs: update from the 2021 illicit drug reporting system interviews |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111623/ https://www.ncbi.nlm.nih.gov/pubmed/35184346 http://dx.doi.org/10.1111/dar.13448 |
work_keys_str_mv | AT priceolivia covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews AT dietzepaulm covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews AT maherlisa covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews AT crawfordsione covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews AT peacockamy covid19vaccineacceptabilityamongpeopleinaustraliawhoinjectdrugsupdatefromthe2021illicitdrugreportingsysteminterviews |